← Back to catalogue

OPTIGEN® Allergen-Specific IgE Assay - US Inhalant 36(100 ND)

FDA UDI

Class II (US FDA UDI)

by Minaris Medical America, Inc.

Identity

Trade Name
OPTIGEN® Allergen-Specific IgE Assay - US Inhalant 36(100 ND) FDA UDI
Generic Name
Allergen-specific immunoglobulin E (IgE) antibody IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
KIT, OPTIGEN US Inhalant 36 (100 ND) FDA UDI
Model / Reference
85081 FDA UDI
Description
KIT, OPTIGEN US Inhalant 36 (100 ND) FDA UDI

Identifiers

Catalog Number
85081 FDA UDI
Primary DI / UDI-DI
00813382010426 FDA UDI
FDA Product Code
PUW FDA UDI
GMDN Term
Allergen-specific immunoglobulin E (IgE) antibody IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5750 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Allergen-specific immunoglobulin E (IgE) antibody IVD, kit, chemiluminescent immunoassay

OPTIGEN® Allergen-Specific IgE Assay - US Inhalant 36(100 ND) by Minaris Medical America, Inc. — Class II — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Allergen-specific immunoglobulin E (IgE) antibody IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI cebb3ff1-526f-40bf-ac13-33edf457f57b 36 fields · synced May 30, 2026